Venlafaxine XR Product Recall (2019-12-20)
- Starting date:
- December 20, 2019
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-71949
Last updated: 2019-12-23
Summary
-
Product:
- Venlafaxine XR 37.5 mg Capsule
- Teva-Venlafaxine XR 150 mg Capsule
- Venlafaxine XR 37.5 mg Capsule
- Teva-Venlafaxine XR 150 mg Capsule
Reason
The dissolution is out of trend in the affected lot.
Depth of distribution
Healthcare Establishments, Retailers
Affected products
-
Venlafaxine XR 37.5 mg Capsule
DIN, NPN, DIN-HIM
DIN 02354713
Dosage form
Capsule (Extended Release)
Strength
Venlafaxine hydrochloride 37.5 mg
Lot or serial number
W05930
Companies
- Recalling Firm
-
Sanis Health
243 Consumers Road
Toronto
M2J 4W8
Ontario
CANADA
- Marketing Authorization Holder
-
Sanis Health
243 Consumers Road
Toronto
M2J 4W8
Ontario
CANADA
B. Teva-Venlafaxine XR 150 mg Capsule
DIN, NPN, DIN-HIM
DIN 02275058
Dosage form
Capsule (Extended Release)
Strength
Venlafaxine hydrochloride 150 mg
Lot or serial number
W07930
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA